301 related articles for article (PubMed ID: 23614651)
1. Recombinant AAV9-TLK1B administration ameliorates fractionated radiation-induced xerostomia.
Timiri Shanmugam PS; Dayton RD; Palaniyandi S; Abreo F; Caldito G; Klein RL; Sunavala-Dossabhoy G
Hum Gene Ther; 2013 Jun; 24(6):604-12. PubMed ID: 23614651
[TBL] [Abstract][Full Text] [Related]
2. TAT-mediated delivery of Tousled protein to salivary glands protects against radiation-induced hypofunction.
Sunavala-Dossabhoy G; Palaniyandi S; Richardson C; De Benedetti A; Schrott L; Caldito G
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):257-65. PubMed ID: 22285666
[TBL] [Abstract][Full Text] [Related]
3. Adenoviral delivery of Tousled kinase for the protection of salivary glands against ionizing radiation damage.
Palaniyandi S; Odaka Y; Green W; Abreo F; Caldito G; De Benedetti A; Sunavala-Dossabhoy G
Gene Ther; 2011 Mar; 18(3):275-82. PubMed ID: 21048794
[TBL] [Abstract][Full Text] [Related]
4. Prevention of radiation-induced salivary hypofunction following hKGF gene delivery to murine submandibular glands.
Zheng C; Cotrim AP; Rowzee A; Swaim W; Sowers A; Mitchell JB; Baum BJ
Clin Cancer Res; 2011 May; 17(9):2842-51. PubMed ID: 21367751
[TBL] [Abstract][Full Text] [Related]
5. Prevention of radiation-induced oral mucositis after adenoviral vector-mediated transfer of the keratinocyte growth factor cDNA to mouse submandibular glands.
Zheng C; Cotrim AP; Sunshine AN; Sugito T; Liu L; Sowers A; Mitchell JB; Baum BJ
Clin Cancer Res; 2009 Jul; 15(14):4641-8. PubMed ID: 19584147
[TBL] [Abstract][Full Text] [Related]
6. Impact of submandibular gland excision on salivary gland function in head and neck cancer patients.
Jaguar GC; Lima EN; Kowalski LP; Pellizon AC; Carvalho AL; Alves FA
Oral Oncol; 2010 May; 46(5):349-54. PubMed ID: 20227906
[TBL] [Abstract][Full Text] [Related]
7. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1479-87. PubMed ID: 20934262
[TBL] [Abstract][Full Text] [Related]
8. Rescue Effects and Underlying Mechanisms of Intragland Shh Gene Delivery on Irradiation-Induced Hyposalivation.
Hai B; Zhao Q; Qin L; Rangaraj D; Gutti VR; Liu F
Hum Gene Ther; 2016 May; 27(5):390-9. PubMed ID: 27021743
[TBL] [Abstract][Full Text] [Related]
9. Enhanced transduction of mouse salivary glands with AAV5-based vectors.
Katano H; Kok MR; Cotrim AP; Yamano S; Schmidt M; Afione S; Baum BJ; Chiorini JA
Gene Ther; 2006 Apr; 13(7):594-601. PubMed ID: 16341060
[TBL] [Abstract][Full Text] [Related]
10. Radiation-induced xerostomia: pathophysiology, clinical course and supportive treatment.
Guchelaar HJ; Vermes A; Meerwaldt JH
Support Care Cancer; 1997 Jul; 5(4):281-8. PubMed ID: 9257424
[TBL] [Abstract][Full Text] [Related]
11. Neurotrophic factor GDNF promotes survival of salivary stem cells.
Xiao N; Lin Y; Cao H; Sirjani D; Giaccia AJ; Koong AC; Kong CS; Diehn M; Le QT
J Clin Invest; 2014 Aug; 124(8):3364-77. PubMed ID: 25036711
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology and management of radiation-induced xerostomia.
Berk LB; Shivnani AT; Small W
J Support Oncol; 2005; 3(3):191-200. PubMed ID: 15915820
[TBL] [Abstract][Full Text] [Related]
13. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer.
Eisbruch A; Kim HM; Terrell JE; Marsh LH; Dawson LA; Ship JA
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):695-704. PubMed ID: 11395238
[TBL] [Abstract][Full Text] [Related]
14. Human adipose tissue‑derived stem cells alleviate radiation‑induced xerostomia.
Xiong X; Shi X; Chen F
Int J Mol Med; 2014 Sep; 34(3):749-55. PubMed ID: 25017690
[TBL] [Abstract][Full Text] [Related]
15. Comparison of radiosensitivity of rat parotid and submandibular glands after different radiation schedules.
Coppes RP; Vissink A; Konings AW
Radiother Oncol; 2002 Jun; 63(3):321-8. PubMed ID: 12142096
[TBL] [Abstract][Full Text] [Related]
16. Loss of TRPM2 function protects against irradiation-induced salivary gland dysfunction.
Liu X; Cotrim A; Teos L; Zheng C; Swaim W; Mitchell J; Mori Y; Ambudkar I
Nat Commun; 2013; 4():1515. PubMed ID: 23443543
[TBL] [Abstract][Full Text] [Related]
17. Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction (MARSH): A pilot, first-in-human study of interferon gamma-stimulated marrow mesenchymal stromal cells for treatment of radiation-induced xerostomia.
Blitzer GC; Glazer T; Burr A; Gustafson S; Ganz O; Meyers R; McDowell KA; Nickel KP; Mattison RJ; Weiss M; Chappell R; Rogus-Pulia NM; Galipeau J; Kimple RJ
Cytotherapy; 2023 Nov; 25(11):1139-1144. PubMed ID: 37589639
[TBL] [Abstract][Full Text] [Related]
18. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.
Chao KS; Deasy JO; Markman J; Haynie J; Perez CA; Purdy JA; Low DA
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):907-16. PubMed ID: 11240231
[TBL] [Abstract][Full Text] [Related]
20. Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms.
Jeong SY; Kim HW; Lee SW; Ahn BC; Lee J
Thyroid; 2013 May; 23(5):609-16. PubMed ID: 23153322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
